DCOY ▲ +28.9% - Decoy Therapeutics Inc. $DCOY - Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding Decoy Therapeutics jumped 28.9% after announcing it is exploring a pan-filovirus therapeutic program under the FDA's Animal Rule pathway, which allows drug approval based on animal efficacy data when human trials are infeasible, and that the company is pursuing non-dilutive funding to support development. The combination of a potentially expedited regulatory route and external funding without shareholder dilution likely drove investor optimism about the program's prospects and financial runway. 22-SEP-2026 07:31 AM ET